- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 35 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 5 residues within 4Å:- Chain A: N.123, A.124, T.125, N.126, F.128
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.342, F.370
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.330, Q.578, L.580
Ligand excluded by PLIPNAG.21: 5 residues within 4Å:- Chain A: N.614, T.616
- Chain C: I.832, K.833, Y.835
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: Y.653, N.655
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.707
- Chain C: I.792, Y.794
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Y.31, N.64
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.165
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: G.231, N.233
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain B: N.123, T.125, N.126, V.127, F.128, V.171
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: Y.31, S.63, N.64
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.353, R.354
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.164, N.165
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.342, F.370
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: N.233
- Chain C: E.464, R.465, D.466
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: N.330, Q.578, T.579, L.580
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain A: K.833, Q.834, Y.835, G.836
- Chain B: N.614
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: Y.653, N.655
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: I.792, Y.794
- Chain B: S.706, N.707
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: A.704, E.1070, N.1072
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain C: N.123, A.124, T.125, N.126, V.127, V.171
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain C: Y.31, F.62, S.63, N.64
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain A: K.461, E.464
- Chain C: N.233, T.235
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.614, T.616
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: Y.653, N.655
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: Y.794
- Chain C: S.706, N.707
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.342, T.344, F.370
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: R.327, P.329, N.330, V.331
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain D: K.398, S.527, N.528
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain D: K.8, N.72, T.74
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain D: K.291, V.298, N.304
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain D: N.35, Q.322
Ligand excluded by PLIP- 1 x ZN: ZINC ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 35 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D